These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 15486887

  • 21. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
    Langer JC, Birnbaum E.
    J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
    [Abstract] [Full Text] [Related]

  • 22. Redo pull-through surgery in Hirschsprung disease: Short-term clinical outcome.
    Dingemans A, van der Steeg H, Rassouli-Kirchmeier R, Linssen MW, van Rooij I, de Blaauw I.
    J Pediatr Surg; 2017 Sep; 52(9):1446-1450. PubMed ID: 27765267
    [Abstract] [Full Text] [Related]

  • 23. Acquired aganglionosis: a rare occurrence following pull-through procedures for Hirschsprung's disease.
    West KW, Grosfeld JL, Rescorla FJ, Vane DW.
    J Pediatr Surg; 1990 Jan; 25(1):104-8; discussion 108-9. PubMed ID: 2299533
    [Abstract] [Full Text] [Related]

  • 24. Transition zone pull-through in Hirschsprung's disease: a tertiary hospital experience.
    Ghosh DN, Liu Y, Cass DT, Soundappan SSV.
    ANZ J Surg; 2017 Oct; 87(10):780-783. PubMed ID: 27581039
    [Abstract] [Full Text] [Related]

  • 25. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
    Thakkar HS, Bassett C, Hsu A, Manuele R, Kufeji D, Richards CA, Agrawal M, Keshtgar AS.
    J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.
    Hosseini SM, Foroutan HR, Bahador A, Khosravi MB, Geramizadeh B, Sabet B, Zeraatian S, Razmi T, Banani SJ.
    Indian J Gastroenterol; 2008 Feb; 27(3):99-102. PubMed ID: 18787278
    [Abstract] [Full Text] [Related]

  • 31. Reoperation for Hirschsprung's disease.
    Weber TR, Fortuna RS, Silen ML, Dillon PA.
    J Pediatr Surg; 1999 Jan; 34(1):153-6; discussion 156-7. PubMed ID: 10022162
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Reoperation for Hirschsprung disease: pathology of the resected problematic distal pull-through.
    Coe A, Collins MH, Lawal T, Louden E, Levitt MA, Peña A.
    Pediatr Dev Pathol; 2012 Jan; 15(1):30-8. PubMed ID: 22111560
    [Abstract] [Full Text] [Related]

  • 38. Re-operations for Hirschsprung's disease: long-term complications.
    Heinrich M, Häberle B, von Schweinitz D, Stehr M.
    Eur J Pediatr Surg; 2011 Oct; 21(5):325-30. PubMed ID: 21879462
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.